Company Filing History:
Years Active: 2009-2021
Title: Michelle Davey: Innovator in Diagnostic Assays
Introduction
Michelle Davey is a prominent inventor based in Brampton, Canada. She has made significant contributions to the field of diagnostic assays, particularly in the development of sensitive testing methods for medical applications. With a total of 3 patents to her name, her work has had a notable impact on healthcare diagnostics.
Latest Patents
One of her latest patents is the "Polyclonal-monoclonal ELISA assay for detecting N-terminus pro-BNP." This specific and sensitive in vitro ELISA assay and diagnostic test kit is designed to determine levels of NT-proBNP protein in various bodily fluids, including blood, serum, plasma, and urine. The assay employs the sandwich ELISA technique to measure circulating NT-proBNP in human plasma. To achieve this, recombinant human proBNP (rhproBNP) was expressed and purified for use as an immunogen. Polyclonal antibodies (PAb) were purified from goat serum through sequential affinity purification, while monoclonal antibodies were raised against specific polypeptides. Additionally, recombinant human NT-proBNP (rhNT-proBNP) was expressed and purified for calibration purposes in measuring human NT-proBNP.
Career Highlights
Throughout her career, Michelle has worked with notable companies such as Nexus Diagnostics and Nanogen. Her expertise in the field has allowed her to develop innovative solutions that enhance diagnostic accuracy and efficiency.
Collaborations
Michelle has collaborated with esteemed colleagues, including George Jackowski and Peter Kupchak. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Michelle Davey is a trailblazer in the field of diagnostic assays, with her innovative work paving the way for improved medical testing methods. Her contributions continue to influence the healthcare industry positively.